Salt CompositionYou Searched
Arzerra 1000mg Solution for Infusion 50ml
Glaxo SmithKline Pharmaceuticals Ltd.
₹168,520
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
Used In
Blood cancer (Chronic lymphocytic leukemia)
Customers also bought
More About Arzerra
Benefits
In Blood cancer (Chronic lymphocytic leukemia) Blood cancer, also called leukemia, is a cancer of the blood-forming tissues, that decreases the body's ability to fight infection. Arzerra 1000mg Solution for Infusion kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. It is an effective medicine but you should discuss the side effects and benefits of this medicine with your doctor. Let your doctor know if any of the side effects bothers you.
Side Effects
The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you're worried about them.
How to use
Your doctor or nurse will give you this medicine. Kindly do not self-administer.
How it works
Arzerra 1000mg Solution for Infusion is a monoclonal antibody. It specifically binds to receptors on cancer cells. Thus it flags the cancer cells for destruction by the body's immune system.
Consult your Doctor: Please consult your doctor regarding the safety of consuming alcohol with Arzerra 1000mg Solution for Infusion . Experts have not found evidence of alcohol impairing the effectiveness of the medicine.
Seek medical advice from your doctor: Arzerra 1000mg Solution for Infusion may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Doctor consultation is advised.
Safe when prescribed by an expert: Arzerra 1000mg Solution for Infusion is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Seek medical advice from your doctor: It is not known whether Arzerra 1000mg Solution for Infusion alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Safe when prescribed by an expert: Arzerra 1000mg Solution for Infusion is safe to use in patients with kidney disease. No dose adjustment of Arzerra 1000mg Solution for Infusion is recommended.
Not Safe: Arzerra 1000mg Solution for Infusion is probably unsafe to use in patients with liver disease and should be avoided. Doctor consultation is advised.
Manufacturer Address
Dr. Annie Besant Road, Mumbai - 400 030
References
Chabner BA, Barnes J, Neal J, et al. Targeted Therapies: Tyrosine Kinase Inhibitors, Monoclonal Antibodies, and Cytokines. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilmans: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 1747-48
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. p. 1011
Ofatumumab (03 Apr. 2025)
Ofatumumab (03 Apr. 2025)
Ofatumumab (03 Apr. 2025)
Disclaimer
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
